CVSA
Covista Inc. · Consumer Cyclical
114.94
1.93%(-2.26)
Close119.00
3.53%(+4.06)
After HoursLast Updated: — ET
52W L: $86.9752W H: $156.26
$114.94
CHG+13.05 (+12.81%)
H$118.80
L$99.01
VOL6.6M
CVSA (1h)
CVSA NEWS
businesswire.com
14h ago
Covista Announces Third Quarter Fiscal Year 2026 Conference Call
CHICAGO--(BUSINESS WIRE)--Covista (the "company" or "Covista") (NYSE: CVSA), the largest healthcare educator in the United States, announced today it will release its third quarter fiscal year 2026 results on Thursday, May 7, 2026, after market close, followed by a conference call at 4:00 p.m. CT (5:00 p.m. ET) the same day to discuss the results. This call can be accessed by dialing +1 877-407-6184 (U.S. participants) or +1 201-389-0877 (international participants) and stating “Covista earning.
businesswire.com
1d ago
Covista Expands Michael Betz's Role to Chief Growth & Innovation Officer
CHICAGO--(BUSINESS WIRE)--Covista (NYSE: CVSA), America's largest healthcare educator, today announced that Michael Betz has been named Chief Growth & Innovation Officer, expanding his responsibilities to include oversight of the company's Marketing organization while retaining his roles as President of Walden University and leader of the Digital organization. In this expanded role, Betz will bring together Covista's two centers of excellence to drive growth through innovation and greater i.
seekingalpha.com
Mar 16
Covista: Tech-Enabled Education In Tandem With Enrollment
I am bullish on Covista due to sustained enrollment growth driven by technology-enabled and AI-integrated healthcare education. CVSA's partnerships with AI leaders like GE Healthcare's HelloAI and Google Cloud position it to address the widening U.S. physician supply gap. CVSA reported Q2 2026 revenue of $503.4M (12.4% YoY growth), with consistent estimate beats and a P/S multiple below peers despite superior growth.
seekingalpha.com
Mar 13
Covista: A Mispriced Bet On The Healthcare Worker Shortage
Covista is trading significantly below its intrinsic value despite short-term headwinds at Chamberlain University. All segments are growing revenue; Walden University's 27% revenue and 13% enrollment growth offset Chamberlain's 1% enrollment decline. Key risks include heavy reliance on Title IV funding and regulatory changes, though long-term healthcare demand and AI-driven career shifts support growth and limit risk.